{
  "docId": "019de071-654d-745b-85a5-9c5714563742",
  "docSlug": "b9624c0093c712a1f54bd63f2a21715c",
  "documentTitle": "Evotec | Results Presentation Deck | 42 slides",
  "authorId": "evotec",
  "authorName": "Evotec",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 42,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "key_takeaways",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "Includes logos for Evotec and Bayer. Mentions PAGANINI trial.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-654d-745b-85a5-9c5714563742/26",
  "deckHref": "/decks/019de071-654d-745b-85a5-9c5714563742",
  "deckJsonHref": "/decks/019de071-654d-745b-85a5-9c5714563742.json",
  "deckAnchorHref": "/decks/019de071-654d-745b-85a5-9c5714563742#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.32,
        "x": 0.43,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Mean relative change in hourly cough frequency assessed over 24-hour periods versus placebo",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "217119d7-f8d4-47d5-84fb-6ad7c3c7248d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.18,
        "x": 0.78,
        "y": 0.28
      },
      "kind": "diagram",
      "text": "Multiple indications potential: RCC, Overactive Bladder, Endometriosis, Others",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89415c1e-4e31-45a6-b585-11d2d87951b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.03,
        "y": 0.28
      },
      "kind": "list",
      "text": "Positive outcome of Phase IIb trial (PAGANINI): Statistically significant improvement in 24-hour cough counts; Positive outcome in efficacy, safety and differentiation; Favourable safety and tolerability profile",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb929e25-b78d-4a42-826b-d91e05d3929e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.94,
        "x": 0.03,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "Detailed efficacy and safety data will be presented by Bayer at upcoming scientific congress",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e4dbedde-5473-4214-b208-93e13768420b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.94,
        "x": 0.03,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "1) Sources: https://conference.thoracic.org/ Poster presented on the ATS 2020 International Conference Virtual Platform 2) Average hourly cough frequency based on 24-hour sound recordings 3) Source: https://media.bayer.com/baynews.nsf/id/A3224676255E5482C125872600261CAE?open&ref=irrefndcd",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00d1ee24-a27d-4169-a267-74fb650febc8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.25,
        "y": 0.1
      },
      "kind": "title",
      "text": "Positive Phase IIb headline data supports best-in-class potential",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36286430-f645-43c0-b12d-88990973a09f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.25,
        "y": 0.18
      },
      "kind": "title",
      "text": "P2X3 antagonist – eliapixant (BAY1817080) Refractory Chronic Cough (RCC)",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96170032-b3e2-433d-9b4a-6c7338a1aa81",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 42,
      "from": 17,
      "beatId": "e0f5a027-cf3a-4678-8b35-256089367577",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The document concludes with a call to action, emphasizing Evotec's growth potential and future plans",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}